Pacira BioSciences, Inc. Shareholders' Equity for the year ending December 31, 2024: USD 778.35 M

Pacira BioSciences, Inc. Shareholders' Equity is USD 778.35 M for the year ending December 31, 2024, a -10.55% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Pacira BioSciences, Inc. Shareholders' Equity for the year ending December 31, 2023 was USD 870.13 M, a 12.27% change year over year.
  • Pacira BioSciences, Inc. Shareholders' Equity for the year ending December 31, 2022 was USD 775.01 M, a 6.11% change year over year.
  • Pacira BioSciences, Inc. Shareholders' Equity for the year ending December 31, 2021 was USD 730.41 M, a 17.87% change year over year.
  • Pacira BioSciences, Inc. Shareholders' Equity for the year ending December 31, 2020 was USD 619.69 M, a 74.59% change year over year.
Key Data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory